These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35372174)

  • 1. Association Between First-Trimester Maternal Cytomegalovirus Infection and Stillbirth: A Prospective Cohort Study.
    Song X; Li Q; Diao J; Li J; Li Y; Zhang S; Chen L; Wei J; Shu J; Liu Y; Sun M; Sheng X; Wang T; Qin J
    Front Pediatr; 2022; 10():803568. PubMed ID: 35372174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area.
    el-Nawawy A; Soliman AT; el Azzouni O; Amer el-S ; Karim MA; Demian S; el Sayed M
    J Trop Pediatr; 1996 Jun; 42(3):154-7. PubMed ID: 8699582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO; Enders M; Hoopmann M; Geipel A; Simonini C; Berg C; Gottschalk I; Faschingbauer F; Schneider MO; Ganzenmueller T; Hamprecht K
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
    Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
    BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal Screening With Use of Immunoglobulin G Avidity for Congenital Cytomegalovirus Infection.
    Tanimura K; Tairaku S; Morioka I; Ozaki K; Nagamata S; Morizane M; Deguchi M; Ebina Y; Minematsu T; Yamada H
    Clin Infect Dis; 2017 Oct; 65(10):1652-1658. PubMed ID: 29020153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
    Chiaie LD; Neuberger P; Vochem M; Lihs A; Karck U; Enders M
    Arch Gynecol Obstet; 2018 Jun; 297(6):1389-1395. PubMed ID: 29404743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Infection among Pregnant Women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions.
    Jin Q; Su J; Wu S
    J Microbiol Biotechnol; 2017 May; 27(5):1005-1009. PubMed ID: 28285497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnitude of the Cytomegalovirus infection among pregnant women attending antenatal clinics in the city of Mwanza, Tanzania.
    Chibwe E; Mirambo MM; Kihunrwa A; Mshana SE
    BMC Res Notes; 2017 Sep; 10(1):489. PubMed ID: 28931421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
    Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
    Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection in pregnancy.
    Yinon Y; Farine D; Yudin MH; ;
    J Obstet Gynaecol Can; 2010 Apr; 32(4):348-354. PubMed ID: 20500943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection.
    Sonoyama A; Ebina Y; Morioka I; Tanimura K; Morizane M; Tairaku S; Minematsu T; Inoue N; Yamada H
    J Med Virol; 2012 Dec; 84(12):1928-33. PubMed ID: 23080498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study.
    Wade CA; Atkinson N; Holmes NE; Hui L
    Aust N Z J Obstet Gynaecol; 2024 Feb; ():. PubMed ID: 38380539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of cytomegalovirus infection during pregnancy in Gonabad, east of Iran: a cross-sectional study.
    Bagheri L; Mokhtarian H; Sarshar N; Ghahramani M
    J Res Health Sci; 2012; 12(1):38-44. PubMed ID: 22888713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing.
    Kamel N; Metwally L; Gomaa N; Sayed Ahmed WA; Lotfi M; Younis S
    Med Princ Pract; 2014; 23(1):29-33. PubMed ID: 24052007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort.
    Leruez-Ville M; Sellier Y; Salomon LJ; Stirnemann JJ; Jacquemard F; Ville Y
    Clin Infect Dis; 2013 May; 56(10):1428-35. PubMed ID: 23392397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study.
    Huang Y; Tang J; Wang H; Yu H; Song Q; Guo X; Li C; Wang J; Liang C; Li S; Li S; Lin Z; Chen Q; Zhong G; Zhuang S; Su Y; Li T; Wu T; Ge S; Zhang J; Xia N
    EBioMedicine; 2022 Mar; 77():103885. PubMed ID: 35183868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological markers as indicators for congenital cytomegalovirus infection.
    Abo-Elwafa HA; Eldin SS; Sharaf AE; Abdelmonem AM
    Egypt J Immunol; 2010; 17(2):1-10. PubMed ID: 23082482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus antibody status at 17-18 weeks of gestation and pre-eclampsia: a case-control study of pregnant women in Norway.
    Strand KM; Odland ML; Iversen AC; Nordbø SA; Vik T; Austgulen R
    BJOG; 2012 Oct; 119(11):1316-23. PubMed ID: 22804776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiological survey of cytomegalovirus infection among pregnant women in Nagasaki, Japan.
    Tagawa M; Minematsu T; Masuzaki H; Ishimaru T; Moriuchi H
    Pediatr Int; 2010 Jun; 52(3):459-62. PubMed ID: 19919637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.